Marksans Pharma Ltd. (MARKSANS): Marksans Pharma Share Price touches fresh 52-week high on intraday move
- September 9, 2026
- Posted by: Harsh Piplani
- Category: News
Marksans Pharma Share Price is trading at Rs 337.30, up Rs 1.40 or 0.42% today, after touching a fresh 52-week high of Rs 337.35. The company’s market capitalisation stands at Rs 15,187.78 crore. This Marksans Pharma Share Price update matters because the stock is already at a yearly high while the broader move remains modest in percentage terms, keeping the focus on the price point itself and the valuation context. According to the latest Univest data, the event is confirmed by the day’s range and the one-year peak, but it does not establish a company-specific catalyst. Investors tracking Marksans Pharma Stock News, Marksans Pharma Share Price Today and Marksans Pharma Share News can use this move as a live reference point on Univest.
The stock opened at Rs 336.35 and moved between Rs 333.75 and Rs 337.35 during the morning session. It is trading just above the previous close of Rs 335.90, and turnover stands at Rs 1.06 crore. Univest records the fresh 52-week high event alongside the current price, which keeps Marksans Pharma Share Price in focus across Marksans Pharma NSE and Marksans Pharma BSE searches.
Marksans Pharma Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 337.3 |
| Previous Close | Rs 335.9 |
| Today's Move | +Rs 1.4 (+0.42%) |
| Open | Rs 336.35 |
| High | Rs 337.35 |
| Low | Rs 333.75 |
| Turnover | Rs 1.06 crore |
| Market Capitalisation | Rs 15,187.78 crore |
Marksans Pharma Ltd. (MARKSANS) traded at Rs 337.3 versus the previous close of Rs 335.9, a rise of 0.42%. The stock opened at Rs 336.35, reached a high of Rs 337.35 and touched a low of Rs 333.75.
Marksans Pharma Share Price Today shows a narrow move around the day’s upper band. The stock last traded at Rs 337.30, compared with the previous close of Rs 335.90, and the day change of Rs 1.40 translates into 0.42%. The open at Rs 336.35 was close to the previous close, while the low of Rs 333.75 marked the weakest point seen so far in the morning session. The high of Rs 337.35 is the fresh 52-week high and sits just Rs 0.05 above the last traded price, which means the stock is trading near that intraday peak. Turnover of Rs 1.06 crore provides the rupee value attached to today’s dealings. For readers following Marksans Pharma Stock Performance on Univest, this is the main price event to track during Marksans Pharma Share Price Live coverage.
From an event perspective, the key fact is simple: Marksans Pharma Share Price has reached a new 52-week high without any verified company-specific trigger in the data record. That makes the move notable for Stock Market Today and Share Market Today screens, but the interpretation should stay factual. The price action confirms a fresh yearly high and keeps Marksans Pharma News Today in the Stocks in News category.
Marksans Pharma Ltd. (MARKSANS) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 15,187.78 crore |
| P/E Ratio | 29.46x |
| P/B Ratio | 4.79x |
| ROE | 15.31% |
| ROCE | 21.1% |
| EPS | Rs 11.4 |
| Book Value Per Share | Rs 70.16 |
| Dividend Yield | 0.27% |
Marksans Pharma Ltd. (MARKSANS) fundamental metrics show P/E 29.46x, P/B 4.79x, ROE 15.31%, ROCE 21.1%. These figures provide context only and are not a buy or sell signal.
Marksans Pharma Ltd. has a market capitalisation of Rs 15187.78 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 29.46x, P/B at 4.79x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 15.31% and ROCE of 21.1%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 11.4, book value per share of Rs 70.16, dividend yield of 0.27%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.68x, median ROE of 11.81%, median ROCE of 13.68%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 29.46x |
| Benchmark Median P/E | 32.68x |
| Benchmark Average P/E | 49.25x |
| Benchmark P/E Range | 3.39x to 668.68x |
| Company P/B Ratio | 4.79x |
| Benchmark Median P/B | 3x |
| Company ROE | 15.31% |
| Benchmark Median ROE | 11.81% |
| Company ROCE | 21.1% |
| Benchmark Median ROCE | 13.68% |
| Company Market Capitalisation | Rs 15,187.78 crore |
| Benchmark Median Market Cap | Rs 704.3 crore |
Marksans Pharma Ltd. (MARKSANS) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Marksans Pharma Ltd. (MARKSANS) has a P/E ratio of 29.46x, which is below the benchmark median of 32.68x, a difference of -9.85%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Marksans Pharma Ltd. (MARKSANS) has a ROE of 15.31%, which is above the benchmark median of 11.81%, a difference of +29.64%. Marksans Pharma Ltd. (MARKSANS) has a ROCE of 21.1%, which is above the benchmark median of 13.68%, a difference of +54.24%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Jubilant Pharmova Ltd. | JUBLPHARMA | 15,176.31 | 45.15 | 2.23 | 5.97 | 8.69 |
| Concord Biotech Ltd. | CONCORDBIO | 15,090.89 | 55.83 | 7.42 | 13.54 | 18.04 |
| Natco Pharma Ltd. | NATCOPHARM | 15,019.26 | 12.93 | 1.58 | 16.3 | 17.16 |
| Sudeep Pharma Ltd. | SUDEEPPHRM | 14,958.35 | 83.05 | 16.42 | 25.37 | 28.5 |
| Alembic Pharmaceuticals Ltd. | APLLTD | 15,717.19 | 22.94 | 2.72 | 12.35 | 11.74 |
Marksans Pharma Ltd. (MARKSANS) has a P/E ratio of 29.46x compared with the displayed peer median of 45.15x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 15.31% compares with a peer median of 13.54% across the companies shown in the table. ROCE stood at 21.1% versus the displayed peer median of 17.16%, providing a capital-efficiency comparison. Marksans Pharma Ltd. (MARKSANS) has a market capitalisation of Rs 15,187.78 crore. Among the 5 peers shown, 1 has a larger market capitalisation.
Why Investors Are Watching Marksans Pharma
- Marksans Pharma Share Price touched a fresh 52-week high of Rs 337.35 and was last traded at Rs 337.30.
- The stock is up Rs 1.40 or 0.42% from the previous close of Rs 335.90.
- Turnover stands at Rs 1.06 crore during the morning session.
- Market capitalisation is Rs 15,187.78 crore, with P/E at 29.46 and P/B at 4.79.
- ROE is 15.31% and ROCE is 21.1%, both above the same-industry medians on Univest.
About Marksans Pharma
Marksans Pharma Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. In this Marksans Pharma Share Price note, the company is being viewed through its valuation, quarterly revenue record, earnings metrics and industry benchmark position. Univest tracks it within the NSE and BSE ecosystem so readers can connect the current price event with the company’s basic financial profile.
The available financial record includes revenue, net profit, EPS, book value and dividend yield, which together help frame Marksans Pharma Stock Analysis for readers following Marksans Pharma Latest News and Marksans Pharma Company News. The company’s market cap and ratio profile are the most relevant company-level metrics in this article.
Frequently Asked Questions
Why did Marksans Pharma Share Price hit a fresh 52-week high today?
Ans. Marksans Pharma Share Price touched Rs 337.35, its fresh 52-week high, and last traded at Rs 337.30. The record confirms the price event, but the data does not establish a company-specific catalyst.
What is Marksans Pharma Share Price today?
Ans. Marksans Pharma Share Price is Rs 337.30, up Rs 1.40 or 0.42% from the previous close of Rs 335.90. The stock is trading near its intraday high in morning trade on Univest.
What is the market capitalisation of Marksans Pharma?
Ans. Marksans Pharma has a market capitalisation of Rs 15,187.78 crore. That places the company close to the same-industry average in the healthcare and pharmaceuticals group used for this comparison.
How does Marksans Pharma compare on valuation?
Ans. Marksans Pharma has a P/E of 29.46 and a P/B of 4.79. Its P/E is below the same-industry median, while its P/B is above the median and slightly above the benchmark average.
What do ROE and ROCE show for Marksans Pharma?
Ans. Marksans Pharma reports ROE of 15.31% and ROCE of 21.1%. Both are above the same-industry medians, which adds useful context for readers following Marksans Pharma Fundamental Analysis on Univest.
What are the key earnings metrics for Marksans Pharma?
Ans. EPS is Rs 11.4, book value per share is Rs 70.16 and dividend yield is 0.27%. These metrics help explain the earnings, accounting value and payout profile behind Marksans Pharma Share Price.
How is Marksans Pharma positioned in its industry group?
Ans. Marksans Pharma sits in the Pharmaceuticals & Drugs industry within Healthcare. Its P/E is below the industry median, while its ROE and ROCE are above the same-industry medians in the Univest benchmark set.
Where can I track Marksans Pharma Share Price Live?
Ans. You can track Marksans Pharma Share Price Live on Univest, along with the current price, 52-week high, market capitalisation, valuation ratios and recent company updates in one place for quick reference.
Track Marksans Pharma Share Price on Univest
Use Marksans Pharma Ltd. (MARKSANS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Marksans Pharma Share Price on Univest for live price updates, 52-week levels, company fundamentals, sector benchmarks and related market insights. Univest also helps readers follow Marksans Pharma Share Price Today, Marksans Pharma Share Price Update, Marksans Pharma Financial Results and Marksans Pharma Latest News in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
